| Product Code: ETC088672 | Publication Date: Jun 2021 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Cambodia Radiopharmaceutical Market was estimated at USD 458 Million in 2025 and is projected to reach USD 626 Million by 2032, growing at a CAGR of 4.6% from 2026 to 2032. This trajectory is fueled primarily by a rising incidence of chronic diseases, particularly cancer, which necessitates advanced diagnostic tools. As the healthcare sector in Cambodia evolves, increasing investments in nuclear medicine and imaging technologies are further driving the demand for radiopharmaceuticals.
The Cambodia radiopharmaceutical market has shown stable growth, with an anticipated annual increase of 5.0% in 2021, followed by a slight rise to 5.6% in 2022 and remaining steady at that rate through 2023. This steady growth can be attributed to rising consumer demand for targeted cancer therapies and advancements in imaging technologies that enhance diagnostic capabilities. From 2024 to 2027, the growth dipped slightly, averaging around 5.1%, reflecting minor fluctuations in investment levels and regulatory developments. However, renewed enthusiasm from industry players and government support for healthcare infrastructure has led to a rebound, with projections indicating a return to a 5.6% growth rate by 2031.
This graph highlights how the Cambodia Radiopharmaceutical Market has steadily grown over the past five years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | 5.0% | New manufacturing facilities enhance local radiopharmaceutical production capacity |
| 2022 | 5.6% | Radiopharmaceutical production investments boosted local supply chain reliability |
| 2023 | 5.6% | New radiopharmaceutical manufacturing facilities boost local production capacity |
| 2024 | 5.4% | Local radiopharmaceutical production investments boosted supply chain resilience |
| 2025 | 5.0% | Technology integration enhanced radiopharmaceutical production efficiency and quality standards |
| 2026 | 5.3% | Local research facilities boost radiopharmaceutical development and manufacturing capabilities |
| 2027 | 5.1% | New radiopharmaceutical facility boosts local manufacturing capabilities significantly |
| 2028 | 5.5% | New healthcare facility constructions boost radiopharmaceutical supply chain investments |
| 2029 | 5.2% | Domestic radiopharmaceutical manufacturing expansion drives raw material sourcing needs |
| 2030 | 5.5% | Accelerated adoption of radiopharmaceutical technology boosted production capabilities |
| 2031 | 5.6% | Local assembly facilities boost radiopharmaceutical supply chain resilience |
| 2032 | 5.4% | Strengthened reactor maintenance schedules boosted radiopharmaceutical production capacity |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
Recent momentum in the Cambodia radiopharmaceutical market indicates a robust phase of growth, driven by heightened awareness and adoption of nuclear medicine. However, despite this positive trend, the market still faces challenges in infrastructure and regulatory frameworks that could impede future expansion.
Looking ahead, the ongoing modernization of Cambodia's healthcare system is expected to create substantial opportunities for radiopharmaceuticals. While the current landscape shows promise, overcoming barriers such as limited accessibility and educational gaps will be crucial for sustained growth in the coming years.
Despite the promising outlook, the Cambodia radiopharmaceutical market grapples with significant restraints that hinder its growth. The absence of local manufacturing capabilities forces reliance on imports, making the supply chain vulnerable to fluctuations and regulatory changes. Furthermore, there is a noticeable gap in awareness regarding the benefits of radiopharmaceuticals among both healthcare providers and patients. This lack of education limits the market's potential, as many remain unaware of the diagnostic and therapeutic advantages offered by nuclear medicine. Lastly, the complexities involved in obtaining regulatory approvals and the high costs associated with establishing radiopharmaceutical facilities further complicate market entry and expansion efforts.
Current trends in the Cambodia radiopharmaceutical market include an increasing integration of advanced medical imaging technologies, which enhance the precision and effectiveness of diagnostics. The rise in cancer incidences has particularly propelled the demand for radiopharmaceuticals in oncology treatments, reflecting a broader trend towards personalized medicine. Additionally, public awareness campaigns initiated by healthcare institutions are gradually bridging the knowledge gap surrounding nuclear medicine, encouraging more patients to seek radiopharmaceutical interventions.
The Cambodia radiopharmaceutical market presents multiple avenues for growth and investment. The burgeoning demand for reliable diagnostic tools amidst the rising incidence of chronic diseases creates a fertile ground for investors. Opportunities also lie in establishing local manufacturing plants to reduce dependency on imports, which could enhance supply chain stability. Furthermore, collaborations with governmental bodies and healthcare institutions can facilitate the introduction of innovative products and technologies, addressing the healthcare needs of the Cambodian population effectively.
While there are currently no specific policies targeting the radiopharmaceutical market, the Cambodian government's focus on enhancing healthcare infrastructure indirectly supports this sector. The Ministry of Health oversees the regulatory framework for pharmaceutical products, ensuring safety and quality standards are met. Stakeholders looking to enter the market should remain attuned to regulatory updates and initiatives that the government may introduce, which could impact the landscape of radiopharmaceutical usage in Cambodia.
The Cambodia radiopharmaceutical market is set for continued growth between 2026 and 2032, primarily driven by advancements in healthcare infrastructure and increasing healthcare needs. As chronic diseases become more prevalent, the demand for accurate and efficient diagnostic tools will soar. Enhanced accessibility to medical imaging technologies, paired with government support for healthcare improvements, is likely to bolster the adoption of radiopharmaceuticals in various medical fields, including oncology and cardiology. However, addressing existing awareness gaps and streamlining regulatory processes will be essential for maximizing the market's potential.
In recent months, the Cambodia radiopharmaceutical market has seen a growing interest in nuclear medicine technologies, with various healthcare facilities exploring partnerships to integrate advanced imaging solutions. There are ongoing discussions about improving regulatory processes to facilitate the importation and use of radiopharmaceuticals. Additionally, awareness initiatives are on the rise, aiming to educate both healthcare providers and the public about the benefits of nuclear medicine, marking a significant step towards expanding market acceptance.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cambodia Radiopharmaceutical Market Overview |
3.1 Cambodia Country Macro Economic Indicators |
3.2 Cambodia Radiopharmaceutical Market Revenues & Volume, 2022 & 2032F |
3.3 Cambodia Radiopharmaceutical Market - Industry Life Cycle |
3.4 Cambodia Radiopharmaceutical Market - Porter's Five Forces |
3.5 Cambodia Radiopharmaceutical Market Revenues & Volume Share, By Types, 2022 & 2032F |
3.6 Cambodia Radiopharmaceutical Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.7 Cambodia Radiopharmaceutical Market Revenues & Volume Share, By Procedural Volume Assessment, 2022 & 2032F |
3.8 Cambodia Radiopharmaceutical Market Revenues & Volume Share, By Source, 2022 & 2032F |
3.9 Cambodia Radiopharmaceutical Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 Cambodia Radiopharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring nuclear medicine procedures |
4.2.2 Growing awareness and adoption of advanced radiopharmaceuticals for diagnostic and therapeutic purposes |
4.2.3 Technological advancements in radiopharmaceutical manufacturing and imaging technologies |
4.3 Market Restraints |
4.3.1 Lack of skilled healthcare professionals for handling radiopharmaceuticals |
4.3.2 Limited availability of regulatory framework and infrastructure for radiopharmaceutical distribution and storage |
5 Cambodia Radiopharmaceutical Market Trends |
6 Cambodia Radiopharmaceutical Market, By Types |
6.1 Cambodia Radiopharmaceutical Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Cambodia Radiopharmaceutical Market Revenues & Volume, By Types, 2022-2032F |
6.1.3 Cambodia Radiopharmaceutical Market Revenues & Volume, By Diagnostic Nuclear Medicine, 2022-2032F |
6.1.4 Cambodia Radiopharmaceutical Market Revenues & Volume, By Therapeutic Nuclear Medicine, 2022-2032F |
6.2 Cambodia Radiopharmaceutical Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Cambodia Radiopharmaceutical Market Revenues & Volume, By Diagnostic Applications, 2022-2032F |
6.2.3 Cambodia Radiopharmaceutical Market Revenues & Volume, By Therapeutic Applications, 2022-2032F |
6.3 Cambodia Radiopharmaceutical Market, By Procedural Volume Assessment |
6.3.1 Overview and Analysis |
6.3.2 Cambodia Radiopharmaceutical Market Revenues & Volume, By Diagnostic Procedures, 2022-2032F |
6.3.3 Cambodia Radiopharmaceutical Market Revenues & Volume, By Therapeutic Procedures, 2022-2032F |
6.4 Cambodia Radiopharmaceutical Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Cambodia Radiopharmaceutical Market Revenues & Volume, By Nuclear Reactors, 2022-2032F |
6.4.3 Cambodia Radiopharmaceutical Market Revenues & Volume, By Cyclotrons, 2022-2032F |
6.5 Cambodia Radiopharmaceutical Market, By End-users |
6.5.1 Overview and Analysis |
6.5.2 Cambodia Radiopharmaceutical Market Revenues & Volume, By Hospitals, 2022-2032F |
6.5.3 Cambodia Radiopharmaceutical Market Revenues & Volume, By Ambulatory Surgical Centers, 2022-2032F |
6.5.4 Cambodia Radiopharmaceutical Market Revenues & Volume, By Diagnostic Centers, 2022-2032F |
6.5.5 Cambodia Radiopharmaceutical Market Revenues & Volume, By Cancer Research Institutes, 2022-2032F |
6.5.6 Cambodia Radiopharmaceutical Market Revenues & Volume, By Others, 2022-2032F |
7 Cambodia Radiopharmaceutical Market Import-Export Trade Statistics |
7.1 Cambodia Radiopharmaceutical Market Export to Major Countries |
7.2 Cambodia Radiopharmaceutical Market Imports from Major Countries |
8 Cambodia Radiopharmaceutical Market Key Performance Indicators |
8.1 Number of nuclear medicine procedures performed annually in Cambodia |
8.2 Investment in research and development of new radiopharmaceutical products |
8.3 Adoption rate of advanced radiopharmaceutical imaging technologies in healthcare facilities |
9 Cambodia Radiopharmaceutical Market - Opportunity Assessment |
9.1 Cambodia Radiopharmaceutical Market Opportunity Assessment, By Types, 2022 & 2032F |
9.2 Cambodia Radiopharmaceutical Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.3 Cambodia Radiopharmaceutical Market Opportunity Assessment, By Procedural Volume Assessment, 2022 & 2032F |
9.4 Cambodia Radiopharmaceutical Market Opportunity Assessment, By Source, 2022 & 2032F |
9.5 Cambodia Radiopharmaceutical Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 Cambodia Radiopharmaceutical Market - Competitive Landscape |
10.1 Cambodia Radiopharmaceutical Market Revenue Share, By Companies, 2025 |
10.2 Cambodia Radiopharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here